Skip to main content
SpringerLink
Log in

Impact of Inhaled and Intranasal Corticosteroids on the Growth of Children

  • Review Article
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

Since inhaled and intranasal corticosteroids may be systemically bioavailable, risk of growth suppression cannot be ruled out in children treated with these compounds. The mechanisms by which exogenous corticosteroids can cause growth suppression may be multifactorial, involving influences on growth hormone secretory profiles and insulin-like growth factor-I activity, direct effects on the epiphyseal growth plate, and effects on bone and collagen turnover. When studies on growth in children treated with inhaled and intranasal corticosteroids are interpreted, it is important to discriminate between data on the final outcome of growth (adult height) and data on growth rate. No firm conclusions can be drawn on adult height from the available data. While the data on children treated with inhaled corticosteroids appear reassuring, there are no peer-reviewed studies on the final height of children treated with intranasal corticosteroids. The possibility of additive effects on the final height or growth rate of children receiving intranasal plus inhaled corticosteroids has also not been studied. When assessing the risk of growth rate suppression, specific corticosteroids, doses and inhaler systems must be evaluated separately. Standard paediatric doses of inhaled corticosteroids (budesonide 200 to 400 μg/day delivered from a metered dose inhaler with a spacer, dry powder budesonide 200 μg/day, or dry powder fluticasone propionate 200 μg/day) do not affect growth rate when a twice daily administration regimen is used. The risk of growth rate suppression in children treated with inhaled budesonide depends on the dosage and may become significant with 800 μg/day administered with a spacer, or with 400 μg/day administered with a dry powder device. When high doses of inhaled corticosteroids are used, the risk of adverse effects on growth rate can be reduced by once daily dosage in the morning. In fact, intranasal mometasone furoate 100 and 200μg from an aqueous pump spray and dry powder budesonide 200 and 400μg once daily in the morning have been found not to affect growth rate. Sensitivity to adverse effects on growth rate may vary between individuals. If growth suppression is detected, ‘catch-up growth’ may be expected when the dose of the inhaled or intranasal corticosteroid is reduced or other treatment modalities are introduced. Inhaled or intranasal corticosteroids should not be withheld from children with asthma or rhinitis. Topical corticosteroids should be given in doses that control disease symptoms; however, height measurements should be performed regularly in children receiving corticosteroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Brown HB, Storey G. Beclomethasone dipropionate steroid aerosol in treatment of perennial allergic asthma in children. BMJ 1973; 3: 161–4

    Article  PubMed  CAS  Google Scholar 

  2. Oberger E, Engström I, Karlberg J. Long-term treatment with glucocorticosteroids/ ACTH in asthmatic children. III. Effects on growth and adult height. Acta Paediatr Scand 1990; 79: 77–83

    Article  PubMed  CAS  Google Scholar 

  3. Wolthers OD, Pedersen S. Short term linear growth in asthmatic children during treatment with prednisolone. BMJ 1990; 303: 145–8

    Article  Google Scholar 

  4. Fuller RW, Barnes PJ. Mechanisms of asthma, bronchial hyper-responsiveness, and actions of glucocorticosteroids in asthma. In: Hargreave FE, Hogg JC, Malo JL, et al. editors. Glucocorticosteroids and mechanisms of asthma. Amsterdam: Excerpta Medica, 1989: 5–12

    Google Scholar 

  5. Ellul-Micallef R. Glucocorticosteroids — the pharmacological basis of their therapeutic use Bronchial asthma. In: Barnes PJ, Rodger IW, Thomson NC, editors. Asthma: Basic mechanisms and clinical management. London: Academic Press, 1990: 653–91

    Google Scholar 

  6. Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 325: 860–9

    Article  PubMed  CAS  Google Scholar 

  7. Orgel HA, Meltzer EO, Kemp JP, et al. Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray orpressurized aerosol. J Allergy Clin Immunol 1986; 77: 858–64

    Article  PubMed  CAS  Google Scholar 

  8. Bisgaard H, Grnborg H, Mygind N, et al. Allergen-induced increase in eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990; 85: 891–5

    Article  PubMed  CAS  Google Scholar 

  9. Barnes PJ. The changing face of asthma. Q J Med 1987; 359–65

  10. Pipkorn U, Norman PS, Middleton Jr E. Topical steroids. In: Mygind N, Weeke B, editors. Allergic and vasomotor rhinitis: clinical aspects. Copenhagen: Munksgaard, 1985: 165–79

    Google Scholar 

  11. Lindqvist N, Andersson M, Bende M, et al. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989; 19: 71–6

    Article  PubMed  CAS  Google Scholar 

  12. Wolthers OD, Honour JW. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids. Clin Exp Allergy 1998; 28: 545–50

    PubMed  CAS  Google Scholar 

  13. Wolthers OD, Honour JW. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticosteroids: clinical and research implications. J Asthma 1999; 36: 477–86

    Article  PubMed  CAS  Google Scholar 

  14. Hindmarsh PC, Brook CGD. Normal growth and its endocrine control. In: Brook CDG, editor. Clinical paediatric endocrinology. Oxford: Backwell Scientific Publications, 1989: 57–73

    Google Scholar 

  15. Vermeulen A. Nyctohermeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab 1987; 64: 884–8

    Article  PubMed  CAS  Google Scholar 

  16. Heuck C, Skjærbæk C, Ørskov H, et al. Circadian variation in serum free ultrafiltrable insulin-like growth factor-I concentrations in healthy children. Pediatric Res 1999; 45: 733–6

    Article  CAS  Google Scholar 

  17. Isaksson OGP, Lindahl A, Nilsson A, et al. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987; 8: 426–38

    Article  PubMed  CAS  Google Scholar 

  18. Guler HP, Zapf J, Schmid C, et al. Insulin-like growth factors I and II in healthy man: estimations of half-lives and production rates. Acta Endocrinol 1989; 121: 753–8

    PubMed  CAS  Google Scholar 

  19. Bar RS, Clemmons DR, Boes M, et al. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 1990; 127: 1078–86

    Article  PubMed  CAS  Google Scholar 

  20. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990; 70: 591–614

    PubMed  CAS  Google Scholar 

  21. Graham MF. The use of serum levels of procollagen propeptides to predict growth velocity. J Pediatr Gastroenterol Nutr 1989; 8: 143–5

    Article  PubMed  CAS  Google Scholar 

  22. Burgeson RE. New collagen, new concepts. Ann Rev Cell Dev Biol 1988; 4: 551–77

    Article  CAS  Google Scholar 

  23. Morris HG. Growth and skeletal maturation in asthmatic children: effect of corticosteroid treatment. Pediatr Res 1975; 9: 579–83

    Article  PubMed  CAS  Google Scholar 

  24. Kjellstrand CM. Side effects of steroids and their treatment. Transplant Proc 175; 7: 123–9

  25. Blodgett FM, Burgin L, Iezzoni D, et al. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med 1956; 254: 636–41

    Article  PubMed  CAS  Google Scholar 

  26. Van Metre TE, Pinkerton HL. Growth suppression in asthmatic children receiving prolonged therapy with prednisone and methylprednisolone. J Allergy 1959; 30: 103–13

    Article  Google Scholar 

  27. Falliers CJ, Tan LS, Szentivanyi J, et al. Childhood asthma and steroid therapy as influences on growth. Am J Dis Child 1963; 105: 127–37

    Google Scholar 

  28. Chang KC, Miklich DR, Barwise G, et al. Linear growth of asthmatic children: the effects of the disease and various forms of steroid therapy. Clin Allergy 1982; 12: 369–78

    Article  PubMed  CAS  Google Scholar 

  29. Goldey DH, Mansmann HC, Rasmussen AI. Zinc status of asthmatic, prednisone-treated asthmatic, and non-asthmatic children. J Am Diet Assoc 1984; 84: 157–63

    PubMed  CAS  Google Scholar 

  30. Drever JC, Malone DNS, Grant IWB, et al. Corticotrophin after corticosteroids in children with asthma and growth retardation. Br J Dis Chest 1975; 69: 188–94

    Article  PubMed  CAS  Google Scholar 

  31. Allen DB, Mullen ML, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994; 93: 967–76

    Article  PubMed  CAS  Google Scholar 

  32. Shapiro GG. Corticosteroids in the treatment of allergic disease: Principles and practice. Pediatr Clin North Am 1983; 30: 955–71

    PubMed  CAS  Google Scholar 

  33. Kerrebijn KF, De Kroon PM. Effect on height of corticosteroid therapy in asthmatic children. Arch Dis Child 1968; 43: 556–61

    Article  PubMed  CAS  Google Scholar 

  34. Prader A. Catch-up growth. Postgrad Med J 1978; 54 Suppl. 1: 133–43

    PubMed  Google Scholar 

  35. Miell JP, Corder R, Pralong FP, et al. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers. J Clin Endocrinol Metab 1991; 72: 675–81

    Article  PubMed  CAS  Google Scholar 

  36. Allen DB. Influence of inhaled corticosteroids on growth: a pediatric endocrinologists perspective. Acta Paediatr 1998; 87: 123–9

    Article  PubMed  CAS  Google Scholar 

  37. Miell JP, Taylor AM, Jones J, et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 1993; 136: 525–33

    Article  PubMed  CAS  Google Scholar 

  38. Wolthers OD, Juul A, Hansen M, et al. The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child 1994; 71: 409–13

    Article  PubMed  CAS  Google Scholar 

  39. Wolthers OD, Juul A, Hansen M, et al. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide. Acta Paediatr Scand 1995; 84: 393–7

    Article  CAS  Google Scholar 

  40. Miell JP. Glucocorticoids and GH secretion: current Medical Literature. Growth and Growth Factors 1991; 6: 63–9

    Google Scholar 

  41. Blum WF, Ranke MB, Kietzmann K, et al. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991; 5: 539–44

    Article  PubMed  CAS  Google Scholar 

  42. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 1993; 16: 341–6

    Article  PubMed  CAS  Google Scholar 

  43. Wolthers OD, Hansen M, Juul A, et al. Urine Cortisol excretion, knemometry and measures of the insulin-like growth factor axis and collagen turnover in the assessment of systemic activity of inhaled glucocorticosteroids in children. Pediatric Res 1997; 41: 44–50

    Article  CAS  Google Scholar 

  44. Heuck C, Wolthers OD, Kollerup G, et al. Short term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 1997; 62: 659–64

    Article  PubMed  CAS  Google Scholar 

  45. Falliers CF, Szentivanyi J, McBride M, et al. Growth rate of children with intractable asthma. J Allergy 1961; 32: 420–34

    Article  PubMed  CAS  Google Scholar 

  46. Friedman M, Strang LB. The effects of corticosteroid and ACTH therapy on growth and on the hypothalamic-pituitary adrenal axis of children. Scand J Respir Dis 1969; 68 (Suppl. ): 58–69

    CAS  Google Scholar 

  47. Murray AB, Fraser B, Hardwick DF, et al. Chronic asthma and growth failure in children. Lancet 1976; II: 197–8

    Article  Google Scholar 

  48. Hauspie R, Susanne C, Alexander F. A mixed longitudinal study of the growth in height and weight in asthmatic children. Hum Biol 1976; 48: 271–83

    PubMed  CAS  Google Scholar 

  49. Snyder RD, Collipp PJ, Greene JS. Growth and ultimate height of children with asthma. Clin Ped 1967; 6: 389–92

    Article  Google Scholar 

  50. Hauspie R, Susanne C, Alexander F. Maturational delay and temporal growth retardation in asthmatic boys. J Allergy Clin Immunol 1977; 59: 200–6

    Article  PubMed  CAS  Google Scholar 

  51. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 1049–55

    Article  PubMed  CAS  Google Scholar 

  52. Ferguson F, Murray AB, Tze W-J. Short stature and delayed skeletal maturation in children with allergic disease. J Allergy Clin Immunol 1982; 69: 461–6

    Article  PubMed  CAS  Google Scholar 

  53. Martin AJ, Landau LI, Phelan PD. The effect on growth of childhood asthma. Acta Paediatr Scand 1981; 70: 683–8

    Article  PubMed  CAS  Google Scholar 

  54. Gilliam GL, McNicol KN, Williams HE. Chest deformity, residual airways obstruction and hyperinflammation, and growth in children with asthma. Arch Dis Child 1970; 45: 789–99

    Article  Google Scholar 

  55. Ninan TK, Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 1992; 67: 703–5

    Article  PubMed  CAS  Google Scholar 

  56. McCowan C, Neville RG, Thomas GE, et al. Effect of asthma on growth: four year follow up of cohort of children from general practices in Tayside, Scotland. BMJ 1998; 316: 668–72

    Article  PubMed  CAS  Google Scholar 

  57. Pike MG, Chang CL, Atherton DJ, et al. Growth in atopic eczema: a controlled study by questionnaire. Arch Dis Child 1989; 64: 1566–9

    Article  PubMed  CAS  Google Scholar 

  58. Massarano AA, Hollis S, Devlin J, et al. Growth in atopic eczema. Arch Dis Child 1993; 68: 677–9

    Article  PubMed  CAS  Google Scholar 

  59. Sorva RA, Turpeinen MT. Asthma, glucocorticoids and growth. Ann Med 1994; 26: 309–14

    Article  PubMed  CAS  Google Scholar 

  60. Balfour-Lynn L. Childhood asthma and puberty. Arch Dis Child 1985; 60: 231–5

    Article  PubMed  CAS  Google Scholar 

  61. Shohat M, Shohat T, Kedem R, et al. Childhood asthma and growth outcome. Arch Dis Child 1987; 62: 63–5

    Article  PubMed  CAS  Google Scholar 

  62. Karlberg J, Gelander L, Albertsson-Wikland K. Distinctions between short- and long-term human growth studies. Acta Paediatr 1993; 82: 631–4

    PubMed  CAS  Google Scholar 

  63. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99: 466–74

    Article  PubMed  CAS  Google Scholar 

  64. Godfrey S, König P. Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Arch Dis Child 1974; 49: 591–6

    Article  PubMed  CAS  Google Scholar 

  65. Francis RS. Long-term beclomethasone dipropionate aerosol therapy in juvenile asthma. Thorax 1976; 31: 309–14

    Article  PubMed  CAS  Google Scholar 

  66. Kerrebijn KF. Beclomethasone dipropionate in long-term treatment of asthma in children. J Pediatr 1976; 89: 821–6

    Article  PubMed  CAS  Google Scholar 

  67. Godfrey S, Balfour-Lynn L, Tooley M. A three- to five-year follow-up of the use of the aerosol steroid, beclomethasone dipropionate, in childhood asthma. J Allergy Clin Immunol 1978; 62: 335–9

    Article  PubMed  CAS  Google Scholar 

  68. Graff-Lonnevig V, Kraepelin S. Long-term treatment with beclomethasone dipropionate aerosol in asthmatic children, with special reference to growth. Allergy 1979; 34: 57–61

    Article  PubMed  CAS  Google Scholar 

  69. Littlewood JM, Johnson AW, Edwards PA, et al. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988; I (8577): 115–6

    Article  Google Scholar 

  70. Verini M, Verrotti A, D’Arcangelo A, et al. Long-term therapy in childhood asthma: clinical and auxological aspects. Eur Rev Med Pharmacol Sci 1990; 12: 169–73

    CAS  Google Scholar 

  71. Phillip M, Aviram M, Leiberman E, et al. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 1992: 12: 84–9

    Article  PubMed  CAS  Google Scholar 

  72. Brown DCP, Savacool AM, Letizia CM. A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth patterns of asthmatic children. Ann Allergy 1989; 63: 47–51

    PubMed  CAS  Google Scholar 

  73. Ribeiro LB. A 12 month tolerance study with budesonide in asthmatic children. In: Godfrey S, editor. Glucocorticosteroids in childhood asthma. Amsterdam: Excerpta Medica, 1987: 95–108

    Google Scholar 

  74. Varsano I, Volovitz B, Malik H, et al. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 1990; 85: 914–20

    Article  PubMed  CAS  Google Scholar 

  75. Ribeiro LB. Budesonide: safety and efficacy aspects of its long-term use in children. Pediatr Allergy Immunol 1993; 4: 73–8

    Article  PubMed  CAS  Google Scholar 

  76. Merkus PJ, van Essen-Zandvliet EE, Duiverman EJ, et al. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91: 1121–6

    PubMed  CAS  Google Scholar 

  77. Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64–77

    PubMed  CAS  Google Scholar 

  78. Agertoft L, Pedersen S. Effects of long-term treatment with inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373–81

    Article  PubMed  CAS  Google Scholar 

  79. Ruiz RGG, Price JE. Growth and adrenal responsiveness with budesonide in young asthmatics. Respir Med 1994; 88: 17–20

    Article  PubMed  CAS  Google Scholar 

  80. Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Crit Care Med 1995; 151: 1715–9

    CAS  Google Scholar 

  81. Saha M-T, Laippala P, Lenko HL. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids. Acta Paediatr 1997; 86: 138–42

    Article  PubMed  CAS  Google Scholar 

  82. Price JF, Russell G, Hindmarsh PC, et al. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 1997; 24: 178–86

    Article  PubMed  CAS  Google Scholar 

  83. Brown HB, Bhowmik M, Jackson FA, et al. Beclomethasone dipropionate aerosols in the treatment of asthma in childhood. Practitioner 1980; 224: 847–51

    PubMed  CAS  Google Scholar 

  84. Nassif E, Weinberger M, Sherman B, et al. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1987; 80 (4): 518–29

    Article  PubMed  CAS  Google Scholar 

  85. Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994; 83: 196–9

    Article  PubMed  CAS  Google Scholar 

  86. Todd G, Dunlop K, McNaboe J, et al. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996; 348: 27–9

    Article  PubMed  CAS  Google Scholar 

  87. Whitaker K, Webb J, Barnes J, et al. Effect of fluticasone on growth in children with asthma. Lancet 1996; 348: 63–4

    Article  PubMed  CAS  Google Scholar 

  88. Findlay CA, MacDonald JF, Wallace AM, et al. Childhood Cushings syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ 1998; 317: 739–40

    Article  PubMed  CAS  Google Scholar 

  89. Hermanussen M, Geiger-Benoit K, Burmeister J, et al. Knemometry in childhood: accuracy and standardization of a new technique of lower leg length measurement. Ann Hum Biol 1988; 15: 1–16

    Article  PubMed  CAS  Google Scholar 

  90. Michaelsen KF, Skov L, Badsberg JH, et al. Short term measuremnets of linear growth in preterm infants: validation of a handheld knemometer. Pediatr Res 1991; 30: 464–8

    Article  PubMed  CAS  Google Scholar 

  91. Wolthers OD. Methodological aspects of short-term knemometry in the assessment of exogenous glucocorticoid-induced growth suppression in children. Ann Hum Biol 1997; 24: 539–46

    Article  PubMed  CAS  Google Scholar 

  92. Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry. Acta Paediatr 1993; 82: 1066–71

    Article  PubMed  CAS  Google Scholar 

  93. Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991; 301: 163–5

    Article  Google Scholar 

  94. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89: 839–42

    PubMed  CAS  Google Scholar 

  95. Wolthers OD, Pedersen S. Growth in asthmatic children during treatment with budesonide. Pediatrics 1993; 90: 517–8

    Google Scholar 

  96. Heuck C, Wolthers OD, Kollerup G, et al. Adverse effects of high doses of inhaled glucocorticoids on growth and collagen turnover in asthmatic children: a double blind comparison of once versus twice daily administration. J Pediatr 1998; 133: 608–12

    Article  PubMed  CAS  Google Scholar 

  97. Wolthers OD, Pedersen S. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993; 68: 673–6

    Article  PubMed  CAS  Google Scholar 

  98. Visser MJ, van Aalderen WM, Elliott BM, et al. Short-term growth in asthmatic children using fluticasone propionate. Chest 1998; 113: 584–6

    Article  PubMed  CAS  Google Scholar 

  99. Agertoft L, Pedersen S. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J 1997; 10: 1507–12

    Article  PubMed  CAS  Google Scholar 

  100. Heuck C, Heickendorff L, Wolthers OD. Arandomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide. Arch Dis Child. In press

  101. Ferguson AC, Spier S, Manjra A, et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999; 134: 422–7

    Article  PubMed  CAS  Google Scholar 

  102. Wolthers OD, Pedersen S. Short term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993; 82: 635–40

    PubMed  CAS  Google Scholar 

  103. Agertoft L, Pedersen S. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. J Allergy Clin Immunol 1999; 104: 948–52

    Article  PubMed  CAS  Google Scholar 

  104. Wolthers OD, Pedersen S. Knemometric assessment of the systemic activity of once daily intranasal drypowder budesonide in children. Eur J Allergy Clin Immunol 1994; 49: 96–9

    Article  CAS  Google Scholar 

  105. Marshall WA. Evaluation of growth rate in height over periods of less than one year. Arch Dis Child 1971; 46: 414–20

    Article  PubMed  CAS  Google Scholar 

  106. Marshall WA. The relationship of variations in children’s growth rates to seasonal climatic influences. Ann Hum Biol 1975; 2: 243–50

    Article  PubMed  CAS  Google Scholar 

  107. Butler GE, McKie M, Ratcliffe SG. The cyclical nature of prepubertal growth. Ann Hum Biol 1990; 17: 177–98

    Article  PubMed  CAS  Google Scholar 

  108. Voss LD, Wilkin TJ, Bailey BJR, et al. The reliability of height and height velocity in the assessment of growth. Arch Dis Child 1991; 66: 833–7

    Article  PubMed  CAS  Google Scholar 

  109. Hermanussen M, Burmeister J. Standards for the predictive accuracy of short term body height and lower leg length measurements on half annual growth rates. Arch Dis Child 1989; 64: 259–63

    Article  PubMed  CAS  Google Scholar 

  110. Wolthers OD, Konstantin-Hansen K, Pedersen S, et al. Knemometry in the assessment of short-term linear growth in a population of healthy school children. Horm Res 1992; 37: 156–9

    Article  PubMed  CAS  Google Scholar 

  111. Doull IJ, Campbell MJ, Holgate ST. Duration of growth suppressive effects of regular inhaled corticosteroids. Arch Dis Child 1998; 78: 172–3

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Randers Hospital, DK-8900, Randers, Denmark

    Ole D. Wolthers (Consultant Paediatrician)

Authors
  1. Ole D. Wolthers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ole D. Wolthers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolthers, O.D. Impact of Inhaled and Intranasal Corticosteroids on the Growth of Children. BioDrugs 13, 347–357 (2000). https://doi.org/10.2165/00063030-200013050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200013050-00005

Keywords

Search

Navigation